Seer to Present Virtually at the 40th Annual J.P. Morgan Healthcare Conference
December 29 2021 - 8:05AM
Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing
a disruptive new platform for proteomics, today announced that the
company will participate in the upcoming 40th Annual J.P. Morgan
Healthcare Conference.
Seer’s management is scheduled to present and
participate in a Q&A session on Monday, January 10 at 8:15 a.m.
Pacific Time / 11:15 a.m. Eastern Time. A live webcast of the
virtual session will be available on the Investor section of Seer’s
website at investor.seer.bio. An archived replay will be available
on the company’s website following the conference.
About Seer
Seer™ is a life sciences company developing
transformative products that open a new gateway to the proteome.
Seer is commercializing its Proteograph™ Product Suite, an
integrated solution that includes proprietary engineered
nanoparticles, consumables, automation instrumentation and software
to perform deep, unbiased proteomic analysis at scale in a matter
of hours. Seer designed the Proteograph workflow to be efficient
and easy to use, leveraging widely adopted laboratory
instrumentation to provide a decentralized solution that can be
incorporated by nearly any lab. Seer’s Proteograph Product Suite is
for research use only and is not intended for diagnostic
procedures. For more information, please
visit www.seer.bio.
Investor ContactCarrie
Mendivilinvestor@seer.bio
Media ContactKaren Possematopr@seer.bio
Seer (NASDAQ:SEER)
Historical Stock Chart
From Jun 2024 to Jul 2024
Seer (NASDAQ:SEER)
Historical Stock Chart
From Jul 2023 to Jul 2024